Prepare for 2025 ICD-10-CM Coding Updates - PowerPoint PPT Presentation

About This Presentation
Title:

Prepare for 2025 ICD-10-CM Coding Updates

Description:

ICD-10-CM updates for 2025 will become effective on October 1, 2024. These updates will include several guideline changes as well as multiple updates & additions to the specific chapters. This webinar will discuss the new guidelines as well as specific code categories in which you need to be alert to changes that may impact your code selection. All chapters will be included to ensure your specialty is covered. It is important that you be proactive and prepared when submitting your claims with discharge dates of October 1. The missed update information may cause a processing & reimbursement delay. – PowerPoint PPT presentation

Number of Views:7
Date added: 13 September 2024
Slides: 17
Provided by: confpanel5
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: Prepare for 2025 ICD-10-CM Coding Updates


1
IcD 10-cm updates for 2025
  • Dorothy D. SteeD
  • MSLD, CCS, CDIP, COC, CPCO, CPUM, CPUR, CPHM,
    CPMA, ACS-OP, CCS-P, RCC, RMC, CEMC, CPC-I, CFPC,
    PCS, FCS, CRCR, CICA, CPAR
  •  

2
Guidelines updates
  • Sepsis due to a postprocedural infection For
    sepsis following a postprocedural wound (surgical
    site) infection, a code from T81.41 to T81.43,
    Infection following a procedure, T81.49,
    Infection following a procedure, other surgical
    site, or a code from O86.00 to O86.03, Infection
    of obstetric surgical wound, or code O86.09,
    Infection of obstetric surgical wound, other
    surgical site, that identifies the site of the
    infection should be sequenced first, if known.
    Assign an additional code for sepsis following a
    procedure (T81.44) or sepsis following an
    obstetrical procedure (O86.04). Use an additional
    code to identify the infectious agent. If the
    patient has severe sepsis, the appropriate code
    from subcategory R65.2 should also be assigned
    with the additional code(s) for any acute organ
    dysfunction.
  • If a patient admission/encounter is chiefly for
    the administration of chemotherapy, immunotherapy
    or external beam radiation therapy assign code
    Z51.0, Encounter for antineoplastic radiation
    therapy, or Z51.11, Encounter for antineoplastic
    chemotherapy, or Z51.12, Encounter for
    antineoplastic immunotherapy as the first-listed
    or principal diagnosis.

3
Neoplasms Chapter 2
  • Hodgkin Lymphomas C81x C84x
  • There are multiple code clarifications that add
    in remission or not having achieved remission
  • Non-Hodgkin Lymphomas C85x C86x
  • There are multiple code clarifications that add
    in remission or not having achieved remission
  • C88 Malignant immunoproliferative diseases and
    certain other B-cell lymphomas
  • There are multiple code clarifications that add
    not having achieved remission

4
Diseases of blood blood-forming organs immune
mechanisms Chapter 3
  • D61 Other aplastic anemias and other bone marrow
    failure syndromes
  • D61.03 Fanconi anemia
  • D89.83 Cytokine release syndrome
  • Use Additional code for adverse effect, if
    applicable, to identify immune checkpoint
    inhibitors and immunostimulant drugs (T45.AX5)

5
Endocrine, nutritional metabolic diseases
chapter 4
  • E08 E09 Diabetes mellitus due to underlying
    condition
  • E10.A Type 1 diabetes mellitus, presymptomatic
  • Additional descriptors
  • Early-stage type 1 diabetes mellitus
  • E10.A0 Type 1 diabetes mellitus, presymptomatic,
    unspecified
  • E10.A1 Type 1 diabetes mellitus,
    presymptomatic, Stage 1
  • Multiple confirmed islet autoantibodies with
    normoglycemia
  • E10.A2 Type 1 diabetes mellitus, presymptomatic,
    Stage 2
  • Confirmed islet autoimmunity with dysglycemia

6
Mental, Behavioral and Neurodevelopmental
disorders Chapter 5
  • F50.020 Anorexia nervosa, binge eating/purging
    type, mild
  • Anorexia nervosa, binge eating/purging type,
    with a body mass index greater than or equal to
    17 kg/m2
  • F50.021 Anorexia nervosa, binge eating/purging
    type, moderate
  • Anorexia nervosa, binge eating/purging type,
    with a body mass index of 16.0-16.99 kg/m2
  • F50.022 Anorexia nervosa, binge eating/purging
    type, severe
  • Anorexia nervosa, binge eating/purging type, with
    a body mass index of 15.0-15.99 kg/m2
  • F50.023 Anorexia nervosa, binge eating/purging
    type, extreme
  • Anorexia nervosa, binge eating/purging type, with
    a body mass index of less than 15.0 kg/m2
  • F50.024 Anorexia nervosa, binge eating/purging
    type, in remission
  • Anorexia nervosa, binge eating/purging type, in
    full remission
  • Anorexia nervosa, binge eating/purging type, in
    partial remission
  • F50.029 Anorexia nervosa, binge eating/purging
    type, unspecified

7
Diseases of the nervous system chapter 6
  • G40.8 Other epilepsy and recurrent seizures
  • G40.84 KCNQ2-related epilepsy
  • G40.841 KCNQ2-related epilepsy, not intractable,
    with status epilepticus
  • G40.842 KCNQ2-related epilepsy, not intractable,
    without status epilepticus
  • KCNQ2-related epilepsy NOS
  • G40.843 KCNQ2-related epilepsy, intractable, with
    status epilepticus
  • G40.844 KCNQ2-related epilepsy, intractable,
    without status epilepticus

8
Diseases of the circulatory system chapter 9
  • I16.1 Hypertensive emergency
  • Use Additional code, if applicable, to identify
    specific organ dysfunction, such as
  • acute kidney injury (N17.-)
  • acute myocardial infarction (I21.-)
  • acute pulmonary edema (left and/or right
    ventricular failure) (J81.0, I50.-)
  • aortic dissection (I71.0-)
  • cerebral hemorrhage (I60.-. I61.-, I62.-)
  • cerebral infarction (I63.-)Add eclampsia (O15.-)
  • hypertensive encephalopathy (I67.4)
  • seizure (R56.9)

9
Diseases of the respiratory system chapter 10
  • J34.82 Nasal valve collapse
  • Nasal valve compromise
  • Nasal valve stenosis
  • Code first underlying cause, such as
  • deviated nasal septum (J34.2)
  • J34.820 Internal nasal valve collapse
  • J34.8200 Internal nasal valve collapse,
    unspecified
  • J34.8201 Internal nasal valve collapse, static
  • Narrowing of the septum, head of the inferior
    turbinate and the upper lateral cartilage
  • J34.8202 Internal nasal valve collapse, dynamic
  • Collapse or falling of the upper, middle sidewall
    of the nose on inspiration
  • J34.821 External nasal valve collapse
  • J34.8210 External nasal valve collapse,
    unspecified Add
  • J34.8211 External nasal valve collapse, static
  • Fixed narrowing of the caudal septum, lower
    lateral cartilage, alar rim and nasal sill
  • J34.8212 External nasal valve collapse, dynamic
  • Collapse or falling of the lower sidewall or
    nostril of the nose on inspiration
  • J34.829 Nasal valve collapse, unspecified

10
Diseases of the digestive system chapter 11
  • K60.3 Anal fistula Add Code first, if applicable
  • Crohn's disease (K50.-)
  • ulcerative colitis (K51.-)
  • K60.30 Anal fistula, unspecified
  • Anal fistula NOS
  • K60.31 Anal fistula, simple
  • Low intersphincteric anal fistula
  • Superficial anal fistula
  • K60.311 Anal fistula, simple, initial
  • Anal fistula, simple, new
  • K60.312 Anal fistula, simple, persistent
  • Anal fistula, simple, chronic
  • K60.313 Anal fistula, simple, recurrent
  • Anal fistula simple, occurring following complete
    healing
  • K60.319 Anal fistula, simple, unspecified

11
Diseases of the skin subcutaneous tissue
chapter 12
  • L29.8 Other pruritus
  • L29.81 Cholestatic pruritus
  • Code also, if applicable, type of liver disease
  • Use Additional code for adverse effect, if
    applicable, to identify drug (T36-T50 with fifth
    or sixth character 5)
  • L29.89 Other pruritus
  • L66.10 Lichen planopilaris, unspecified
  • L66.11 Classic lichen planopilaris
  • Follicular lichen planus
  • L66.12 Frontal fibrosing alopecia
  • FFA Add L66.19 Other lichen planopilaris
  • Lassueur Graham-Little Piccardi syndrome
  • L66.81 Central centrifugal cicatricial alopecia
  • L66.89 Other cicatricial alopecia

12
Diseases of musculoskeletal connective tissue
chapter 13
  • M51.360 Other intervertebral disc degeneration,
    lumbar region with discogenic back pain only
    Other intervertebral disc degeneration, lumbar
    region with axial back pain only
  • M51.361 Other intervertebral disc degeneration,
    lumbar region with lower extremity pain only
    Other intervertebral disc degeneration, lumbar
    region with leg pain only
  • Other intervertebral disc degeneration, lumbar
    region with referred sclerotomal pain only
  • M51.362 Other intervertebral disc degeneration,
    lumbar region with discogenic back pain and lower
    extremity pain
  • Other intervertebral disc degeneration, lumbar
    region with discogenic back pain and leg pain
  • Other intervertebral disc degeneration, lumbar
    region with axial back pain and referred
    sclerotomal pain
  • M51.369 Other intervertebral disc degeneration,
    lumbar region without mention of lumbar back pain
    or lower extremity pain
  • Other intervertebral disc degeneration, lumbar
    region without mention of lumbar back pain or leg
    pain
  • Other intervertebral disc degeneration, lumbar
    region, NOS

13
Congenital malformations, deformations and
chromosomal abnormalities chapter 17
  • Q23.81 Bicuspid aortic valve Add Congenital
    bicuspid aortic valve
  • Add Unicuspid (congenital) aortic valve (at
    birth)
  • Add Code also, if applicable, acquired aortic
    valve disorders, such as
  • Add aortic (valve) insufficiency (nonrheumatic)
    (I35.1)
  • Add aortic (valve) stenosis (nonrheumatic)
    (I35.0)
  • Add aortic (valve) stenosis with insufficiency
    (nonrheumatic) (I35.2)
  • Add Q23.82 Congenital mitral valve cleft leaflet
  • Add Cleft mitral valve leaflet at birth
  • Add Q23.88 Other congenital malformations of
    aortic and mitral valves
  • Q87.86 Kleefstra syndrome

14
Injury, poisoning and certain other consequences
of external causes chapter 19
  • T45.A Poisoning by, adverse effect of and
    underdosing of immune checkpoint inhibitors and
    immunostimulant drugs
  • T45.AX Poisoning by, adverse effect of and
    underdosing of immune checkpoint inhibitors and
    immunostimulant drugs
  • T45.AX1 Poisoning by immune checkpoint inhibitors
    and immunostimulant drugs, accidental
    (unintentional)
  • Poisoning by immune checkpoint inhibitors and
    immunosuppressive drugs NOS
  • T45.AX2 Poisoning by immune checkpoint inhibitors
    and immunostimulant drugs, intentional self-harm
  • T45.AX3 Poisoning by immune checkpoint inhibitors
    and immunostimulant drugs, assault T45.AX4
    Poisoning by immune checkpoint inhibitors and
    immunostimulant drugs, undetermined
  • T45.AX5 Adverse effect of immune checkpoint
    inhibitors and immunostimulant drugs
  • T45.AX6 Underdosing of immune checkpoint
    inhibitors and immunostimulant drugs

15
Factors influencing health status and contact
with health services chapter 21
  • Z15.1 Genetic susceptibility to epilepsy and
    neurodevelopmental disorders
  • Code also, if applicable, related disorders such
    as
  • developmental and epileptic encephalopathy
    (G93.45)
  • developmental disorder of speech and language
    (F80.-)
  • developmental disorders of scholastic skills
    (F81.-)
  • epilepsy, by specific type (G40.-)
  • intellectual disabilities (F70-F79)
  • other neurodevelopmental disorder (F88)
  • pervasive developmental disorders (F84.-)

16
Questions???
  • Thank you!
  • dot_at_dorothysteed.com

Register now
Write a Comment
User Comments (0)
About PowerShow.com